Search for: "MUTUAL PHARMACEUTICAL CO." Results 121 - 140 of 255
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Mar 2014, 5:00 am
  Hunt involves allegations that an over-the-counter (“OTC”) drug causes SJS/TENS (the same nasty condition at issue in Mutual Pharmaceutical Co. v. [read post]
1 Feb 2013, 9:42 am by Bexis
Mutual Pharmaceutical Co., 678 F.3d 30 (3d Cir.), cert. granted, 133 S.Ct. 694 (U.S. 2012). [read post]
21 Jun 2013, 4:46 am by Kedar Bhatia
  March (3) Mutual Pharmaceutical Co. v. [read post]
20 Jul 2011, 4:04 am by Marie Louise
– Economic Times reports ‘Letter of Understanding’ between EU and India (Spicy IP) (Generic Pharmaceuticals and IP) France considers paralysing IP rights on the appearance of generic drugs (Class 46) India: Application of Orphan Drug Act to section 3(d)? [read post]
31 Oct 2013, 5:00 am
  We think that the opinion resembles the First Circuit’s decision in Mutual Pharmaceutical Co. v. [read post]
24 Jun 2013, 12:50 pm by Bexis
Mutual Pharmaceutical Co., 678 F.3d 30 (1st Cir. 2012), it essentially dared the Supreme Court to take the case and close off what Bartlett viewed as the plaintiff’s last option – a “pure” design defect claim, with no alternative design offered, explicitly amounting to a claim that – under state law − an FDA-approved product should have been pulled from the market.The Supreme Court has obliged. [read post]
23 Mar 2020, 2:30 am by Matrix Legal Support Service
Unwired Planet International Ltd & Anor v Huawei Technologies (UK) Co Ltd & Anor, Huawei Technologies Co Ltd & Anor v Conversant Wireless Licensing SARL and ZTE Corporation & Anor v Conversant Wireless Licensing SARL, heard 21- 24 October. [read post]
23 Jan 2014, 6:53 am
This post is not from the Dechert side of the blog, because of that firm's involvement in this matter.We mentioned, in the “here’s what’s out there” portion of our 2013 Top Ten post that “The long-pending Lance case (2010 #-6) remains undecided by the Pennsylvania Supreme Court, some three years after oral argument. [read post]
26 Jul 2012, 10:33 am by Ben Cheng
Mutual Pharmaceutical Co., Inc.Docket: 11-1275Issue(s): Whether the Third Circuit has erred in restricting the availability of Section 4 of the Clayton Act, 15 U.S.C. [read post]
18 Jul 2014, 11:55 am
Wyeth Pharmaceuticals, Inc., 2008 WL 7136137 (Ala. [read post]
11 Oct 2013, 1:36 pm by Eric Alexander
                We sometimes take an impish delight in the comments we get from readers who are surprised that we tout defense wins, question the logic of decisions that allow plaintiffs to get past summary judgment with questionable evidence, or—gasp—use sarcasm in how we discuss cases. [read post]
3 Dec 2013, 7:54 am
Ct. 2567 (2011), and Mutual Pharmaceutical Co. v. [read post]
19 Sep 2013, 9:53 am by Bexis
The following post is exclusively the work of the Reed Smith side of the blog.Sometimes the smallest, least significant type of lawsuit can illustrate cracks in the edifice of the largest, most consequential litigation. [read post]